Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.
Hemasphere
; 6(12): e802, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36504547
Full text:
1
Database:
MEDLINE
Type of study:
Observational_studies
/
Systematic_reviews
Language:
En
Journal:
Hemasphere
Year:
2022
Type:
Article
Affiliation country:
Italy